User Fee Programs Will Command Generic Industry’s 2012 Outlook
All eyes of the generic-drug industry will be focused on Capitol Hill this year as Congress readies to take action on the proposed Generic Drug User Fee Act (GDUFA) after years of FDA and industry efforts on the agreement.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.